BYOT Byotrol Plc

 

TIDMBYOT 
 
 
Byotrol PLC 
21 December 2009 
 
? 
 
 
21 December 2009 
 
 
Byotrol plc 
New patent and option agreement 
 
 
The Board of Byotrol plc ('Byotrol' or the 'Company') is pleased to announce 
some positive developments. 
 
A United States patent has now been accepted for the Company's antimicrobial 
technology with the US Patent  Office sending a Letter of Allowance for patent 
application number 10/039677. This application, which  commenced in 2002, 
provides patent protection until 2022 in one of our major markets. 
 
 
The Board is also pleased to announce that, together with its joint venture 
partner Byotrol Consumer Products Limited ("BCP"), the company has entered into 
a six month option agreement, which is extendable by three months, with a 
Fortune 150 corporation with broad international operations. This agreement is 
for exclusive rights to enter into negotiations for a licensing arrangement for 
Byotrol's patented technology. 
 
 
The principal terms of the agreement cover Byotrol's technology in the fields of 
pre-saturated wipes and of liquids for certain surface care markets and 
specifically excludes all currently contracted areas of business. The 
counterparty has agreed to pay Byotrol and BCP jointly a non refundable sum of 
US$250,000 as consideration for the option, with additional sums being payable 
if the option extends beyond six months. 
 
 
Commenting on the developments, David McRobbie, Chief Executive of Byotrol said: 
 
 
"The USA is the world's largest market for technologies such as ours and having 
a granted US patent as well as several ongoing applications both there and in 
the rest of the world is an important platform for our licensing model. 
 
 
"Further, we are pleased that multinational consumer companies are now 
increasing their interest in the Byotrol technology. At this very early stage 
there is no guarantee that this particular agreement will lead to any formal 
supply agreements, but it is an important step forward for the Company." 
 
 
Enquiries: 
 
 
David McRobbie, Chief Executive    0161 277 9518 
Stephen Falder, Deputy Chairman 
Richard Bell, Finance Director 
 
 
Philip Davies / Carl Holmes              020 7149 6000 
Charles Stanley Securities 
Nominated Adviser 
 
 
Tom Cooper / Paul Vann                 020 3043 4162 
Winningtons                                     0797 122 1972 
 
 
Notes to Editors 
 
 
Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene 
company, operating globally in the Health, Food, Leisure, Consumer, Industrial 
and Agriculture sectors, providing a low toxicity product with a broad-based and 
long lasting efficacy across all microbial classes; bacteria, viruses, fungi, 
moulds, microbacteria and algae. 
 
 
The Byotrol product can be used as a stand alone product or as a complementary 
biocide additive to existing products to improve their performance in personal 
hygiene, domestic and industrial disinfection, odour control, food production 
and food management. 
 
 
Founded in 2005, the Company has prioritised the development of a technology 
that creates easier, safer and cleaner lives through partnering with providers 
of essential goods and services. Byotrol is the catalyst behind the aptly named 
global 'Hygiene Revolution'. 
 
 
For more information, please go to www.byotrol.co.uk 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRAUWUNRKVRUAAA 
 

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024